Davide Rozza
Impact in
Papers in
-
- Urticaria and Related Conditions 2
-
- COVID-19 Clinical Research Studies 3
- Co-authors
- Giampiero Mazzaglia (4 shared papers)Carla Fornari (5 shared papers)Paolo Angelo Cortesi (3 shared papers)Greta Carrara (7 shared papers)Sara Conti (3 shared papers)Ippazio Cosimo Antonazzo (5 shared papers)LG Mantovani (5 shared papers)Carlo Alberto Scirè (4 shared papers)
- Journals
- Clinical and Experimental Rheumatology (1 paper)Autoimmunity Reviews (1 paper)Journal of Clinical Medicine (1 paper)Annals of the Rheumatic Diseases (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- ItalyUnited KingdomPortugal
In The Last Decade
Davide Rozza
10 papers receiving 52 citations
Peers
Comparison fields: 5 of 35
- Rheumatology 17
- Applied Microbiology and Biotechnology 2
- Infectious Diseases 18
- Nephrology 6
- Dermatology 7
Countries citing papers authored by Davide Rozza
This map shows the geographic impact of Davide Rozza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Rozza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Rozza more than expected).
Fields of papers citing papers by Davide Rozza
This network shows the impact of papers produced by Davide Rozza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Rozza. The network helps show where Davide Rozza may publish in the future.
Co-authors
The 25 scholars most cited alongside Davide Rozza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2022 | 7 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 7 | |
| 6 | 2022 | 5 | |
| 7 | 2025 | 4 | |
| 8 | 2022 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2025 | 1 | |
| 11 | 2025 | 0 | |
| 12 | 2024 | 0 | |
| 13 | 2024 | 0 | |
| 14 | 2025 | 0 |
About Davide Rozza
Davide Rozza is a scholar working on Rheumatology, Infectious Diseases, Pulmonary and Respiratory Medicine, Molecular Biology and Nephrology, having authored 14 papers that have together received 52 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Urticaria and Related Conditions (2 papers), Vasculitis and related conditions (2 papers), Dermatological and COVID-19 studies (2 papers), Gout, Hyperuricemia, Uric Acid (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Diabetes Management and Research (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Rheumatology (17 citations), Applied Microbiology and Biotechnology (2 citations), Infectious Diseases (18 citations), Nephrology (6 citations) and Dermatology (7 citations). Davide Rozza has collaborated with scholars based in Italy, United Kingdom and Portugal. Frequent co-authors include Giampiero Mazzaglia, Carla Fornari, Paolo Angelo Cortesi, Greta Carrara, Sara Conti, Ippazio Cosimo Antonazzo, LG Mantovani, Carlo Alberto Scirè, Shaniko Kaleci and Giancarlo Cesana. Their work appears in journals such as Clinical and Experimental Rheumatology, Autoimmunity Reviews, Journal of Clinical Medicine, Annals of the Rheumatic Diseases and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.